iNK cells induced apoptosis in breast, colorectal, and endometrial cancer organoids in a dose-dependent manner. Against the same target colorectal cancer organoids, iNKs were more cytotoxic than the ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Gangneung-Wonju National University, Gangneung, Republic of Korea.

Sanofi is to acquire Kiadis, a biotech specialising in therapies based around ‘off the shelf’ natural killer (NK) cells, for 308 million euros ($353 million). The French pharma is buying ...

There are several types—called T cells, B cells, and natural killer (NK) cells—that support the immune system in different ways. The main function of lymphocytes is to recognize and neutralize foreign ...

"DAAN Biotherapeutics and GC Cell agree on CAR-T, CAR-NK therapies" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

OT-C001 is an allogeneic cell therapy of highly activated and expanded NK cells from UCB, manufactured using a patented expansion and activation process. It targets tumor cells through direct and ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...